NAT14 Antikörper (AA 5-33) (PE)

Produktnummer ABIN1916139

Produktdetails anti-NAT14 Antikörper (PE)

Target: NAT14 (N-Acetyltransferase 14 (GCN5-Related, Putative) (NAT14))

Bindungsspezifität: AA 5-33

Reaktivität: Human, Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser NAT14 Antikörper ist konjugiert mit PE

Applikation: Western Blotting (WB), Immunohistochemistry (IHC), ELISA

Spezifität: This NAT14 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 5-33 amino acids from the N-terminal region of human NAT14.

Aufreinigung: Affinity purified

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Approved: ELISA, IHC, WB

Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.

Kommentare:

Target Species of Antibody: Human

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: Lot specific

Buffer: PBS, no preservatives added

Konservierungsmittel: Without preservative

Handhabung: Aliquot to avoid repeated freezing and thawing.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Short term: store at 4°C. Long term: aliquot and store -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.

Haltbarkeit: 6 months

Details zu NAT14

Target: NAT14 (N-Acetyltransferase 14 (GCN5-Related, Putative) (NAT14))

Andere Bezeichnung: NAT14 (NAT14 Produkte)

Synonyme: BC047219 antikoerper, KLP1 antikoerper, N-acetyltransferase 14 antikoerper, N-acetyltransferase 14 (putative) antikoerper, Nat14 antikoerper, NAT14 antikoerper

Hintergrund: Name/Gene ID: NAT14

Synonyms: NAT14, KLP1, N-acetyltransferase 14

Gen-ID: 57106

Pathways: SARS-CoV-2 Protein Interaktom